CorVista Health Announces FDA Clearance of the Novel CorVista System to Detect the Presence of Cardiac Disease
Digital Health Global
SEPTEMBER 12, 2023
WASHINGTON–(BUSINESS WIRE)– #ML — CorVist a Health, Inc., a leading digital health company dedicated to improving cardiovascular disease diagnosis, is pleased to announce the FDA clearance of the CorVista System® with CAD Add-On to evaluate the presence of significant coronary artery disease as an aid in diagnosis.
Let's personalize your content